Abstract:The EGF signaling system plays a major role in the embryo-uterine dialogue during implantation and heparin-binding EGF-like growth factor (HBEGF) serves a role in coordinating embryonic and endometrial development at the site of blastocyst attachment. Implantation in mutant mice lacking HBEGF is delayed, but partially rescued by compensatory upregulation of amphiregulin. As implantation proceeds, HBEGF stimulates trophoblast differentiation and invasive activity essential for placentation. Therefore, we investigated the effects of embryonic HBEGF deficiency on placental development by breeding mice heterozygous for the HBEGF null mutation. Placentas and fetuses were removed on gestation day 14 and weighed. Fetuses were assayed to establish the genotype of corresponding placentas. Placental discs were halved, fixed and embedded in paraffin for sectioning. Central cross sections were deparaffinized for hematoxylin and eosin staining, immunohistochemistry or cell death (TUNEL) assay. Image analysis was used for semiquantification of immunohistochemical staining intensity. Weights of wild type (77.4 ± 3.5 mg; N=12) and heterozygous (76.5 ± 19.3 mg; N=32) placentas were similar, but homozygous null placentas had reduced average weights (59.8 ± 16.0 mg; N=21, p<0.01). Average fetal weight was not significantly affected by genotype. HBEGF immunostaining was gene dose-dependent and differed significantly among the three groups, with heterozygotes having an intermediate level. Other members of the EGF family, amphigreglin, TGF-alpha and EGF were expressed equally in wild type and homozygous null placentas. Histological examination revealed no apparent differences in trophoblast giant cells, but the spongiotrophoblast region was reduced compared to labyrinth in homozygous null placentas. Morphometric assessment of relative area demonstrated that spongiotrophoblast comprised a smaller (p<0.05) proportion of the cross sectional area in null placentas than in the wild type; however, heterozyotes were intermediate and did not differ significantly from the other two genotypes. There were no differences in apoptosis, but proliferation, assessed by nuclear Ki67 staining, was elevated (p<0.05) in the labyrinth and decreased (p<0.05) in the spongiotrophoblast of HBEGF null placentas compared to the wild type. Labyrinth morphology appeared disrupted in HBEGF null placentas stained with laminin to highlight capillary basement membrane. Indeed, the density of laminin-labeled capillaries was decreased (p<0.05) in HBEGF null placentas compared to the wild type, based on morphometric analysis. Immunohistochemical staining revealed reduced vascular endothelial growth factor (VEGF) in both spongiotrophoblast (p=0.06) and labyrinth (p<0.01) regions of HBEGF null placentas, suggesting that poor angiogenesis was due to reduced VEGF. These findings support an active role for HBEGF in placentation. Production of HBEGF by adjacent maternal tissues could have limited the detrimental effects of embryonic HBEGF deficiency. While there was no clear evidence of aberrant giant cell invasion in placentas lacking HBEGF, roles for HBEGF in spongiotrophoblast formation and fetal angiogenesis within the labyrinth were supported. HBEGF could promote fetal capillary formation by inducing VEGF or other angiogenic factors in the developing placenta. Supported by NIH grant HD12304 and the intramural research program of NICHD.

A genetically small fetus impairs placental adaptations near term

Fetal Growth Restriction: Does an Integrated Maternal Hemodynamic-Placental Model Fit Better?

Chronic Protein Restriction in Mice Impacts Placental Function and Maternal Body Weight before Fetal Growth

Effects of excess thromboxane A2 on placental development and nutrient transporters in a Mus musculus model of fetal growth restriction†

PSII-34 Placental GLUT3 (SLC2A3) RNA interference: Impact on fetal growth at mid-gestation

Molecular regulators of defective placental and cardiovascular development in fetal growth restriction

Increased Rat Placental Fatty Acid, but Decreased Amino Acid and Glucose Transporters Potentially Modify Intrauterine Programming

Maternal-fetal interfaces transcriptome changes associated with placental insufficiency and a novel gene therapy intervention

Placental Metabolomics of Fetal Growth Restriction

Placentae of small appropriately-grown-for-gestational-age neonates exhibit sexually dimorphic transcriptomic changes representative of placental insufficiency

Poorly controlled diabetes mellitus alters placental structure, efficiency, and plasticity

Transplacental Nutrient Transport Mechanisms of Intrauterine Growth Restriction in Rodent Models and Humans

Placental regulation of fetal nutrient supply

Placental structure, function, and mitochondrial phenotype relate to fetal size in each fetal sex in mice

Mid-pregnancy placental transcriptome in a model of placental insufficiency with and without novel intervention

Placental alterations in structure and function in intra-uterine growth-retarded horses

Integrated Placental Modelling of Histology with Gene Expression to Identify Functional Impact on Fetal Growth

Angiogenic factors at diagnosis of late-onset small-for-gestational age and histological placental underperfusion

Maternal HBEGF Deficiency Restricts Placentation in Mice.

Maternal diet modulates placental nutrient transporter gene expression in a mouse model of diabetic pregnancy